Tag: 6% benzoyl peroxide

Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%)

Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%)

| October 18, 2010 | 0 Comments

James Q. Del Rosso, DO, Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada; Radhakrishnan Pillai, PhD, Associate Director Project Management, Dow Pharmaceutical Sciences Inc., Petaluma, California; Robert Moore, PhD, Associate Principal Scientist, Dow Pharmaceutical Sciences Inc., Petaluma, California Disclosure: Dr. Del Rosso is a consultant, speaker, and researcher for Coria/Valeant, Allergan, Galderma, Graceway, […]

Continue Reading

A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne

A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne

| August 5, 2010 | 0 Comments

Valerie D. Callender, MD is from Callender Skin and Laser Center, Mitchellville, Maryland. Norman Preston, PhD; Cris Osborn, PhD; Lori Johnson, PhD; and Ronald W. Gottschalk, MD are from Galderma Laboratories, LP, Fort Worth, Texas Disclosure: Dr. Callender is a clinical researcher and consultant for Galderma. Drs. Preston, Osborn, Johnson, and Gottschalk are employed by […]

Continue Reading

A Review of Acne in Ethnic Skin: Pathogenesis, Clinical Manifestations, and Management Strategies

A Review of Acne in Ethnic Skin: Pathogenesis, Clinical Manifestations, and Management Strategies

| April 7, 2010 | 0 Comments

Erica C. Davis, MD; Valerie D. Callender, MD Dr. Davis is from Callender Skin & Laser Center, Mitchellville, Maryland. Dr. Callendar is from Callender Skin & Laser Center, Mitchellville, Maryland and Department of Dermatology, Howard University College of Medicine, Washington, DC.

Continue Reading

A Three-Step Acne System Containing Solubilized Benzoyl Peroxide  versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne

A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne

| November 6, 2009 | 0 Comments

Lawrence F. Eichenfield, MD, Rady Children’s Hospital, San Diego, and University of California San Diego, San Diego, California; Diane Thiboutot, MD, Penn State University College of Medicine, Hershey, Pennsylvania; Alan Shalita, MD, SUNY Downstate Medical Center, Brooklyn, New York; Leonard Swinyer, MD, Dermatology Research Center, Salt Lake City, Utah; Emil Tanghetti, MD, Center for Dermatology […]

Continue Reading

Benzoyl Peroxide  Microsphere Formulations: What is the Science Supporting Microsphere Vehicle Technology and Clinical Use?

Benzoyl Peroxide Microsphere Formulations: What is the Science Supporting Microsphere Vehicle Technology and Clinical Use?

| September 3, 2009 | 0 Comments

James Q. Del Rosso, DO, FAOCD

Continue Reading

The Use of Sodium Sulfacetamide 10%-Sulfur 5% Emollient Foam in the Treatment of Acne Vulgaris

The Use of Sodium Sulfacetamide 10%-Sulfur 5% Emollient Foam in the Treatment of Acne Vulgaris

| August 12, 2009 | 0 Comments

James Q. Del Rosso, DO, FAOCD, Valley Hospital Medical Center, Las Vegas, Nevada Abstract Acne vulgaris is the most common disorder encountered in ambulatory clinical practice comprising 11.3 percent of office visits to dermatologists in 2005.[1] By comparison, eczematous dermatoses, psoriasis, and skin cancer accounted for 6.2, 3.5, and 10 percent of office visits, respectively.[1] […]

Continue Reading

A 6% Benzoyl Peroxide Foaming Cloth Cleanser Used in the Treatment of Acne Vulgaris: Aesthetic Characteristics, Patient Preference Considerations, and Impact on Compliance with Treatment

A 6% Benzoyl Peroxide Foaming Cloth Cleanser Used in the Treatment of Acne Vulgaris: Aesthetic Characteristics, Patient Preference Considerations, and Impact on Compliance with Treatment

| July 3, 2009 | 0 Comments

James Q. Del Rosso, DO, FAOCD Valley Hospital Medical Center, Las Vegas, Nevada Abstract Objective: The study was conducted to evaluate the product attributes of a new benzoyl peroxide-containing foaming cloth cleanser and to compare the overall patient satisfaction of this product with two currently available benzoyl peroxide acne products (6% benzoyl peroxide cleanser and […]

Continue Reading